2021 Annual Meeting - Challenging Cases in GI Malignancies
This is a historically well-attended and well-reviewed session that covers challenging clinical scenarios arising in the management of patients with gastrointestinal malignancies. The discussants will include a radiation oncologist, a medical oncologist, and a surgical oncologist to provide multidisciplinary perspective on management of pancreatic, hepatobiliary, and colorectal cancers. Cases will be chosen to highlight best practices as well as evidence-based approaches to areas of current clinical ambiguity or controversy. The session will be designed with multiple short cases (~ 10 – 12 min) incorporating audience response questions to engage the attendees.
The session is not designed to provide a full review of medical literature related to each disease, but to highlight critical points that can be incorporated into everyday medical decision making. The goal will be to present a mix of difficult scenarios that are commonly encountered in clinical practice (i.e. rectal cancer with oligometastases, decision making for total neoadjuvant therapy for rectal cancer, locally advanced/borderline resectable pancreas cancer, primary liver cancer) with a few less common scenarios (i.e. cholangiocarcinoma) with which the audience may have less direct clinical familiarity but still encounter in a general practice setting.
The activity is designed to meet the interests of radiation oncologists and radiation oncology residents, medical oncologists, surgeons, radiation physicists and diagnostic radiologists.
Upon completion of this activity, participants should be able to:
- Apply current best practices for radiotherapy in the management of borderline resectable pancreas cancer.
- Develop a framework for incorporating total neoadjuvant therapy and hypofractionated radiation in the management of rectal cancer.
- Edward Y. Kim, MD, Department of Radiation Oncology, University of Washington and has no financial relationships with a commercial interest.
- Stacey Alana Cohen, MD, Seattle Cancer Care Alliance / Fred Hutchinson Cancer Research Center and has no financial relationships with a commercial interest.
- Cristina R Ferrone, Department of Surgical Oncology, Massachusetts General Hospital and has no financial relationships with a commercial interest.
- Jennifer Y Wo, Department of Radiation Oncology, Massachusetts General Hospital and has no financial relationships with a commercial interest.
The person(s) above served as the developer(s) of this activity. Additionally, the Education Committee had control over the content of this activity. All relevant relationships have been mitigated.
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing education to physicians.
ASTRO is awarded Deemed Status by the American Board of Radiology to provide SA-CME as part of Part II Maintenance of Certification.
- 1.00 Certificate of AttendanceThis activity was designated for 1.00 AMA PRA Category 1 Credit™.
- 1.00 SA-CME
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing medical education for physicians.
The American Society for Radiation Oncology (ASTRO) designates this for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity meets the American Board of Radiology's criteria for a self-assessment activity in the ABR's Maintenance of Certification program. Participation in this course in combination with the successful completion of the corresponding assessment and course evaluation adheres to the guidelines established by the ABR for 1.00 self-assessment credits.
• No refunds, extensions or substitutions will be made for those registrants who, for any reason, were unable to attend or were tardy for the session.
• No credits will be granted and no refunds, exchanges or transfers will be given to those who do not pass.
• ASTRO staff cannot make modifications to your submitted materials.
One of the two latest versions of Google Chrome, Mozilla Firefox, Internet Explorer or Safari.